DIN 02537516 — NEOSTIGMINE METHYLSULFATE INJECTION, USP 0.5 MG
NEOSTIGMINE METHYLSULFATE INJECTION, USP is a solution of Neostigmine Methylsulfate marketed by JAMP PHARMA CORPORATION. The full Neostigmine Methylsulfate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02537516
- Brand name
- NEOSTIGMINE METHYLSULFATE INJECTION, USP
- Active ingredient
- Neostigmine Methylsulfate
- Strength
- 0.5 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Cholinesterase inhibitor (parasympathomimetic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Neostigmine Methylsulfate products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02475480 | NEOSTIGMINE METHYLSULFATE INJECTION USP | 0.5 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02475499 | NEOSTIGMINE METHYLSULFATE INJECTION USP | 1 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02230593 | NEOSTIGMINE OMEGA | 0.5 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED |
| 02230592 | NEOSTIGMINE OMEGA | 1 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED |
| 02387166 | NEOSTIGMINE OMEGA | 2.5 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |